285 related articles for article (PubMed ID: 16299687)
1. Risk factors and underlying cardiovascular diseases in incident ESRD patients.
Di Benedetto A; Marcelli D; D'Andrea A; Cice G; D'Isa S; Cappabianca F; Pacchiano G; D'Amato R; Oggero AR; Bonanno D; Pergamo O; Calabrò R
J Nephrol; 2005; 18(5):592-8. PubMed ID: 16299687
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular disease in patients with chronic kidney disease: getting to the heart of the matter.
Levin A; Djurdjev O; Barrett B; Burgess E; Carlisle E; Ethier J; Jindal K; Mendelssohn D; Tobe S; Singer J; Thompson C
Am J Kidney Dis; 2001 Dec; 38(6):1398-407. PubMed ID: 11728982
[TBL] [Abstract][Full Text] [Related]
3. Are traditional risk factors valid for assessing cardiovascular risk in end-stage renal failure patients?
Shah DS; Polkinghorne KR; Pellicano R; Kerr PG
Nephrology (Carlton); 2008 Dec; 13(8):667-71. PubMed ID: 18761627
[TBL] [Abstract][Full Text] [Related]
4. The Diamant Alpin Dialysis cohort study: clinico-biological characteristics and cardiovascular genetic risk profile of incident patients.
Pernod G; Bosson JL; Golshayan D; Barro C; Alloatti S; Turc-Baron C; Quarello F; Jeantet A; Von Albertini B; Forêt M; Lauren G; Cordonnier D; Piccoli G; Wauters JP;
J Nephrol; 2004; 17(1):66-75. PubMed ID: 15151261
[TBL] [Abstract][Full Text] [Related]
5. Impact of traditional and novel risk factors on the relationship between socioeconomic status and incident cardiovascular events.
Albert MA; Glynn RJ; Buring J; Ridker PM
Circulation; 2006 Dec; 114(24):2619-26. PubMed ID: 17116764
[TBL] [Abstract][Full Text] [Related]
6. Excess mortality due to interaction between protein-energy wasting, inflammation and cardiovascular disease in chronic dialysis patients.
de Mutsert R; Grootendorst DC; Axelsson J; Boeschoten EW; Krediet RT; Dekker FW;
Nephrol Dial Transplant; 2008 Sep; 23(9):2957-64. PubMed ID: 18400817
[TBL] [Abstract][Full Text] [Related]
7. The association between fibrate use, change in high-density lipoprotein cholesterol, and the risk of cardiovascular disease: a retrospective chart review involving up to 8 years of follow-up.
Nichols GA; Koro CE; Chan W; Bowlin SJ; Sprecher DL
Clin Ther; 2006 Feb; 28(2):243-50. PubMed ID: 16678645
[TBL] [Abstract][Full Text] [Related]
8. Are metalloproteins and acute phase reactants associated with cardiovascular disease in end-stage renal failure?
Healy H; Reith D; Morgan C; Clague A; Westhuyzen J
Ann Clin Lab Sci; 2000 Jul; 30(3):295-304. PubMed ID: 10945571
[TBL] [Abstract][Full Text] [Related]
9. [Cardiovascular risk in hemodialysis in Spain: prevalence, management and target results (MAR study)].
Portolés J; López-Gómez JM; Aljama P
Nefrologia; 2005; 25(3):297-306. PubMed ID: 16053011
[TBL] [Abstract][Full Text] [Related]
10. Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD.
Honda H; Qureshi AR; Heimbürger O; Barany P; Wang K; Pecoits-Filho R; Stenvinkel P; Lindholm B
Am J Kidney Dis; 2006 Jan; 47(1):139-48. PubMed ID: 16377395
[TBL] [Abstract][Full Text] [Related]
11. Bone mineral density in end-stage renal disease patients: association with wasting, cardiovascular disease and mortality.
Matsubara K; Suliman ME; Qureshi AR; Axelsson J; Martola L; Heimbürger O; Barany P; Stenvinkel P; Lindholm B
Blood Purif; 2008; 26(3):284-90. PubMed ID: 18421213
[TBL] [Abstract][Full Text] [Related]
12. Predicting the impact of population level risk reduction in cardio-vascular disease and stroke on acute hospital admission rates over a 5 year period--a pilot study.
Whitfield MD; Gillett M; Holmes M; Ogden E
Public Health; 2006 Dec; 120(12):1140-8. PubMed ID: 17084425
[TBL] [Abstract][Full Text] [Related]
13. Determinants and prognostic importance of cardiomegaly among new ESRD patients in the United States.
Stack AG; Serna H; Ramsanahie A; Henry C
Ann Epidemiol; 2004 Oct; 14(9):676-85. PubMed ID: 15380799
[TBL] [Abstract][Full Text] [Related]
14. [Epidemiology of cardiovascular risk in Chinese chronic kidney disease patients].
Hou FF; Ma ZG; Mei CL; Rong S; Huang SM; Liu XR; Yuan WJ; Guo YS; Wang L; He Q; Wang XL; Sang XH; Li XL
Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(11):753-9. PubMed ID: 15949381
[TBL] [Abstract][Full Text] [Related]
15. Mineral metabolism and cardiovascular morbidity and mortality risk: peritoneal dialysis patients compared with haemodialysis patients.
Noordzij M; Korevaar JC; Bos WJ; Boeschoten EW; Dekker FW; Bossuyt PM; Krediet RT
Nephrol Dial Transplant; 2006 Sep; 21(9):2513-20. PubMed ID: 16799173
[TBL] [Abstract][Full Text] [Related]
16. [Coronary heart disease risk factors in Croatia and worldwide: results of the Interheart study].
Carević V; Rumboldt M; Rumboldt Z;
Acta Med Croatica; 2007 Jun; 61(3):299-306. PubMed ID: 17629106
[TBL] [Abstract][Full Text] [Related]
17. Phospholipid plasmalogen, a surrogate marker of oxidative stress, is associated with increased cardiovascular mortality in patients on renal replacement therapy.
Stenvinkel P; Diczfalusy U; Lindholm B; Heimbürger O
Nephrol Dial Transplant; 2004 Apr; 19(4):972-6. PubMed ID: 15031358
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for vascular complications in patients on peritoneal dialysis.
Arima H; Nakamoto H; Okada S; Inoue T; Kobayashi K; Shoda J; Ikeda N; Kanno Y; Sugahara S; Okada H; Suzuki H
Adv Perit Dial; 2006; 22():192-7. PubMed ID: 16983968
[TBL] [Abstract][Full Text] [Related]
19. Traditional and non-traditional risk factors as contributors to atherosclerotic cardiovascular disease in end-stage renal disease.
Yao Q; Pecoits-Filho R; Lindholm B; Stenvinkel P
Scand J Urol Nephrol; 2004; 38(5):405-16. PubMed ID: 15764253
[TBL] [Abstract][Full Text] [Related]
20. [Prevalence of chronic kidney disease in community-dwelling elderly and associated cardiovascular risk factors].
Almirall J; Vaqueiro M; Antón E; Baré ML; González V; Jaimez E; Gimeno C;
Nefrologia; 2005; 25(6):655-62. PubMed ID: 16514906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
